Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ3W3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,248
Award facts
- Contract value 100% obligated
- $23,248.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rybelsus 7 mg tablets in quantities of 30 units, with a ceiling value of $23,248.01. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is executable through September 19, 2025, and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
Rybelsus is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery order exemplifies the operational flexibility of AmerisourceBergen's prime IDC vehicle with DLA, which enables the company to fulfill pharmaceutical supply needs across multiple therapeutic domains for defense and civilian healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The underlying IDC demonstrates the company's capability to meet federal procurement requirements across open competition, supporting global pharmaceutical supply chains for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FQ3W3?
SPE2DB25FQ3W3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQ3W3 worth?
The government has obligated $23,248 on SPE2DB25FQ3W3.
Is contract SPE2DB25FQ3W3 an order under another contract?
Yes. SPE2DB25FQ3W3 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ3W3 competed?
The extent of competition for SPE2DB25FQ3W3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award